Cargando…
Radiosensitization by a novel Bcl-2 and Bcl-X(L) inhibitor S44563 in small-cell lung cancer
Radiotherapy has a critical role in the treatment of small-cell lung cancer (SCLC). The effectiveness of radiation in SCLC remains limited as resistance results from defects in apoptosis. In the current study, we investigated whether using the Bcl-2/Bcl-X(L) inhibitor S44563 can enhance radiosensiti...
Autores principales: | Loriot, Y, Mordant, P, Dugue, D, Geneste, O, Gombos, A, Opolon, P, Guegan, J, Perfettini, J-L, Pierre, A, Berthier, L K, Kroemer, G, Soria, J C, Depil, S, Deutsch, E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540189/ https://www.ncbi.nlm.nih.gov/pubmed/25232677 http://dx.doi.org/10.1038/cddis.2014.365 |
Ejemplares similares
-
Targeting Bcl-2/Bcl-X(L) Induces Antitumor Activity in Uveal Melanoma Patient-Derived Xenografts
por: Némati, Fariba, et al.
Publicado: (2014) -
Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling
por: Ko, A, et al.
Publicado: (2014) -
Dual Trade of Bcl-2 and Bcl-x(L) in Islet Physiology: Balancing Life and Death With Metabolism Secretion Coupling
por: Soria, Bernat, et al.
Publicado: (2013) -
Time dependent modulation of tumor radiosensitivity by a pan HDAC inhibitor: abexinostat
por: Rivera, Sofia, et al.
Publicado: (2017) -
The prognostic significance of apoptosis-associated proteins BCL-2, BAX and BCL-X in clinical nephroblastoma
por: Ghanem, M A, et al.
Publicado: (2001)